Amai Proteins has announced that its flagship sweet protein, sweelin®, has been approved by the Singapore Food Agency (SFA) for use as a sweetening agent in food and beverage products. This approval follows the product’s recognition as Generally Recognised As Safe (GRAS) by the US Food and Drug Administration, marking a significant step in Amai’s expansion into the Asian market.
sweelin® is a next-generation sweet protein designed to significantly reduce sugar content whilst replacing conventional sweeteners. It offers a clean taste, strong formulation performance, and competitive pricing, making it an attractive alternative for food and beverage manufacturers. The protein can also be labelled as “Serendipity Berry Sweet Protein” in the US, aligning with consumer demand for clean-label and GLP-1-friendly products.
Singapore’s approval of sweelin® underscores the country’s position as a leader in food technology innovation. The nation has initiatives such as the “30 by 30” programme, which aims to produce 30% of its nutritional needs locally by 2030, highlighting its commitment to advanced and sustainable food technologies.
Amai Proteins’ CEO expressed enthusiasm about the approval, stating, “This achievement reinforces the growing global regulatory momentum for sweelin®.” The approval not only expands Amai’s regulatory footprint into Asia but also supports Singapore’s goals in food technology and sustainability.
